1. Home
  2. KPTI vs WIMI Comparison

KPTI vs WIMI Comparison

Compare KPTI & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$7.25

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo WiMi Hologram Cloud Inc.

WIMI

WiMi Hologram Cloud Inc.

HOLD

Current Price

$1.93

Market Cap

31.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
WIMI
Founded
2008
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
31.9M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
KPTI
WIMI
Price
$7.25
$1.93
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.2M
54.0K
Earning Date
05-11-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.36
N/A
P/E Ratio
N/A
$1.24
Revenue Growth
0.57
N/A
52 Week Low
$3.65
$0.26
52 Week High
$10.99
$7.26

Technical Indicators

Market Signals
Indicator
KPTI
WIMI
Relative Strength Index (RSI) 52.46 49.87
Support Level $7.15 $1.56
Resistance Level $7.81 $2.08
Average True Range (ATR) 0.78 0.13
MACD 0.12 0.03
Stochastic Oscillator 55.50 68.18

Price Performance

Historical Comparison
KPTI
WIMI

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: